N Ueno, Y Murakami, T Iwama, T Sasaki, T Kunogi, K Takahashi, K Tanaka, K Ando, S Kashima, Y Inaba, K Moriichi, H Tanabe, M Taruishi, M Fujiya, T Okumura, Journal of Crohn’s and Colitis, Volume 13, Issue Supplement_1, March 2019
P614 The utility as a biomarker of faecal calprotectin for predicting the clinical outcome of granulocyte and monocyte adsorptive apheresis treatment in patients with ulcerative colitis
Fcal is considered to be a useful and objective predictor of the efficacy of GMA treatment in UC patients and superior to symptomatic scores and blood parameters
Faecal calprotectin level for assessing endoscopic activity and predicting future clinical course in patients with moderately active ulcerative colitis undergoing granulomonocytapheresis: a prospective cohort study
Our findings indicate that FC is a relevant biomarker, which is convenient to measure for assessing endoscopic activity and predicting relapse in patients who achieve remission following a course of GMA therapy.
Contact UsFor more informationContact Us